[{"AccountsPayableCurrent_0_Q1_USD":127000000.0,"ContractWithCustomerLiability_0_Q1_USD":342100000.0,"ContractWithCustomerAssetNet_0_Q1_USD":40700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":117000000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q1_USD":-1100000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3000000.0,"OtherNonrecurringIncomeExpense_1_Q1_USD":6200000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":1852100000.0,"LineOfCredit_0_Q1_USD":196300000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":312400000.0,"DeferredFinanceCostsNet_0_Q1_USD":2500000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3000000.0,"RepaymentsOfOtherDebt_1_Q1_USD":300000.0,"OtherLiabilitiesCurrent_0_Q1_USD":401200000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-13000000.0,"ShortTermInvestments_0_Q1_USD":56200000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":3400000.0,"ProceedsFromLinesOfCredit_1_Q1_USD":197500000.0,"LineOfCreditFacilityMaximumBorrowingCapacity_0_Q1_USD":845300000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":798900000.0,"OtherAssetsCurrent_0_Q1_USD":187300000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":12100000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":1200000.0,"TreasuryStockValue_0_Q1_USD":543800000.0,"TreasuryStockShares_0_Q1_shares":19346577.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":6200000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":115000000.0,"EarningsPerShareDiluted_1_Q1_USD":0.07,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":76700000.0,"DividendsCommonStockCash_1_Q1_USD":7400000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-8700000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-15000000.0,"UnrecognizedTaxBenefits_0_Q1_USD":16800000.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_1_Q1_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":424000000.0,"RestructuringReserve_0_Q1_USD":4200000.0,"RestructuringCharges_1_Q1_USD":2300000.0,"PaymentsToMinorityShareholders_1_Q1_USD":1200000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":50000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":22000000.0,"PaymentsForRestructuring_1_Q1_USD":1700000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":300000.0,"OtherNonrecurringExpense_1_Q1_USD":6200000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-11700000.0,"OtherInventoryInTransit_0_Q1_USD":37400000.0,"OtherInventoryDemo_0_Q1_USD":79000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-14500000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":62300000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":44300000.0,"NumberOfReportableSegments_1_Q1_segment":3.0,"NumberOfOperatingSegments_1_Q1_segment":4.0,"LossContingencyAccrualAtCarryingValue_0_Q1_USD":0.0,"LongTermDebtAndCapitalLeaseObligationsCurrent_0_Q1_USD":95800000.0,"LineOfCreditFacilityRemainingBorrowingCapacity_0_Q1_USD":515200000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":133800000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":236600000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":194900000.0,"InformationTechnologyAndDataProcessing_1_Q1_USD":900000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":20400000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-3000000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":10500000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":19000000.0,"CommonStockValueOutstanding_0_Q1_USD":1700000.0,"CommonStockSharesAuthorized_0_Q1_shares":260000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"StockholdersEquity_0_Q1_USD":915600000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":318600000.0,"ProfitLoss_1_Q1_USD":10600000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":600000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":30500000.0,"NetIncomeLoss_1_Q1_USD":10500000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":35000000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-100600000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":191300000.0,"LiabilitiesCurrent_0_Q1_USD":765800000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2961900000.0,"InventoryNet_0_Q1_USD":625500000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-29500000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":2900000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":13500000.0,"GrossProfit_1_Q1_USD":192300000.0,"CostOfRevenue_1_Q1_USD":231700000.0,"CommonStockSharesOutstanding_0_Q1_shares":154226496.0,"CommonStockSharesIssued_0_Q1_shares":173573073.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":795500000.0,"AssetsCurrent_0_Q1_USD":1990000000.0,"Assets_0_Q1_USD":2961900000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-23300000.0,"AccountsReceivableNetCurrent_0_Q1_USD":325500000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":230900000.0,"OperatingExpenses_1_Q1_USD":175900000.0,"OperatingIncomeLoss_1_Q1_USD":16400000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ProceedsFromOtherDebt_1_Q1_USD":1200000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":12700000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":303600000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":154200000.0,"NonoperatingIncomeExpense_1_Q1_USD":-2900000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":100000.0,"MinorityInterest_0_Q1_USD":9000000.0,"LongTermDebtNoncurrent_0_Q1_USD":914800000.0,"LongTermDebt_0_Q1_USD":1010600000.0,"Goodwill_0_Q1_USD":290000000.0,"EarningsPerShareBasic_1_Q1_USD":0.07,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":924600000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":221200000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q1_USD":900000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":452100000.0,"IncreaseDecreaseInInventories_1_Q1_USD":61000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":19100000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.215,"AmortizationOfIntangibleAssets_1_Q1_USD":8700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":155400000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":700000.0,"ShareBasedCompensation_1_Q1_USD":3300000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":121200000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":48500000.0,"PreferredStockValue_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"LegalFees_1_Q1_USD":3400000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_1_Q1_USD":200000.0,"Ticker":"BRKR","CIK":"1109354","name":"BRUKER CORP","OfficialName":"Bruker Corporation Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9329858425.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]